Cargando…

A Retrospective Study of Long Acting Risperidone Use to Support Treatment Adherence in Youth with Conduct Disorder

OBJECTIVE: Risperidone has been widely used to control aggression and conduct disorder (CD) in youth; however, treatment compliance is a major problem in CD. Our aim is to evaluate the effectiveness and tolerability of long-acting risperidone (LAR) in treating nonadherent cases. METHODS: The medical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demirkaya, Sevcan Karakoç, Aksu, Hatice, Özgür, Börte Gürbüz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678487/ https://www.ncbi.nlm.nih.gov/pubmed/29073744 http://dx.doi.org/10.9758/cpn.2017.15.4.328

Ejemplares similares

Factors affecting quality of life of caregivers of children diagnosed with autism spectrum disorder
por: Özgür, Börte Gürbüz, et al.
Publicado: (2018)

The Effect of Congenital and Postnatal Hypothyroidism on Depression-Like Behaviors in Juvenile Rats
por: Özgür, Erdoğan, et al.
Publicado: (2016)

Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louzã, Mário Rodrigues, et al.
Publicado: (2011)

Pathological Internet Use, Aggression, and Cyberbullying in Children and Adolescents With Attention Deficit Hyperactivity Disorder
por: Yasin, Ahmet, et al.
Publicado: (2022)

Assessment of suicidality in children and adolescents with diagnosis of high functioning autism spectrum disorder in a Turkish clinical sample
por: Karakoç Demirkaya, Sevcan, et al.
Publicado: (2016)

Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone
por: Baylé, Franck Jean, et al.
Publicado: (2015)

Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
por: Olfson, Mark, et al.
Publicado: (2007)

Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
por: El-Hage, Wissam, et al.
Publicado: (2010)

Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital
por: Nakamura, Yusuke, et al.
Publicado: (2019)

Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic
por: Chue, Pierre
Publicado: (2007)

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
por: Dilla, Tatiana, et al.
Publicado: (2014)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs, Larry, et al.
Publicado: (2013)

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
por: Samalin, L, et al.
Publicado: (2010)

The cost associated with administering risperidone long-acting injections in the Australian community
por: Dalton, Andrew, et al.
Publicado: (2011)

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
por: Singh, Dhiren, et al.
Publicado: (2009)

Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia
por: Catalán, Rosa, et al.
Publicado: (2011)

Management of Persistent Hyponatremia Induced by Long-acting Injectable Risperidone Therapy
por: Chowdhury, Waliul, et al.
Publicado: (2018)

Risperidone long-acting injection in the treatment of schizophrenia: 24-month results from the electronic Schizophrenia Treatment Adherence Registry in Canada
por: Williams, Richard, et al.
Publicado: (2014)

Risperidone long-acting injection: a review of its long term safety and efficacy
por: Rainer, Michael K
Publicado: (2008)

Evidence based administration of risperidone and paliperidone for the treating conduct disorder
por: Ghanizadeh, Ahmad
Publicado: (2013)

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection
por: Stump, Trevor A., et al.
Publicado: (2021)

Adaptation of the knowledge about childhood autism among health workers questionnaire aimed for usage in Turkey
por: Ozgur, Borte Gurbuz, et al.
Publicado: (2020)

Risperidone in the treatment of conduct disorder in preschool children without intellectual disability
por: Ercan, Eyup S, et al.
Publicado: (2011)

Cumulative effects of risperidone long acting injection and narrative therapy in treating ethanol dependency
por: Trandafir, Maria Silvia
Publicado: (2010)

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
por: Zhao, Yueren, et al.
Publicado: (2013)

Long-Acting Risperidone Dual Control System: Preparation, Characterization and Evaluation In Vitro and In Vivo
por: Yan, Xieguo, et al.
Publicado: (2021)

Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
por: Voss, Erica A., et al.
Publicado: (2015)

Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms
por: Macfadden, Wayne, et al.
Publicado: (2011)

Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct Disorders
por: Piacentino, Daria, et al.
Publicado: (2020)

Efficacy and Safety Profile of Risperidone Long-acting Injection in Adolescents in a Real-life Setting
por: Ardic, Ulku Akyol, et al.
Publicado: (2018)

Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone
por: Perlstein, Itay, et al.
Publicado: (2022)

Efficacy and safety of brand-risperidone versus similar-risperidone in elderly patients with neuropsychiatric disorders: A retrospective study
por: Folquitto, Jefferson Cunha, et al.
Publicado: (2010)

Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France
por: Limosin, Frédéric, et al.
Publicado: (2018)

Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
por: Apiquian, Rogelio, et al.
Publicado: (2011)

Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
por: Macfadden, Wayne, et al.
Publicado: (2011)

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
por: Lambert, Tim, et al.
Publicado: (2011)

Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection
por: Asseburg, Christian, et al.
Publicado: (2012)

Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection
por: Umehara, Hidehiro, et al.
Publicado: (2014)

Use of therapeutic drug monitoring of risperidone microspheres long-acting injection in hemodialysis: A case report
por: Tourtellotte, Rebecca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d7cpulbqba1a05ql3df2tser5t